HomeCompareTESL vs JNJ

TESL vs JNJ: Dividend Comparison 2026

TESL yields 58.34% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TESL wins by $580.3K in total portfolio value
10 years
TESL
TESL
● Live price
58.34%
Share price
$13.49
Annual div
$7.87
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$600.4K
Annual income
$137,323.62
Full TESL calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TESL vs JNJ

📍 TESL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTESLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TESL + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TESL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TESL
Annual income on $10K today (after 15% tax)
$4,958.81/yr
After 10yr DRIP, annual income (after tax)
$116,725.08/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TESL beats the other by $116,021.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TESL + JNJ for your $10,000?

TESL: 50%JNJ: 50%
100% JNJ50/50100% TESL
Portfolio after 10yr
$310.2K
Annual income
$69,075.70/yr
Blended yield
22.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TESL
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TESL buys
0
JNJ buys
0
No recent congressional trades found for TESL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTESLJNJ
Forward yield58.34%3.36%
Annual dividend / share$7.87$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$600.4K$20.0K
Annual income after 10y$137,323.62$827.78
Total dividends collected$495.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TESL vs JNJ ($10,000, DRIP)

YearTESL PortfolioTESL Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$16,534$5,833.89$10,676$355.77+$5.9KTESL
2$26,706$9,014.67$11,407$389.39+$15.3KTESL
3$42,183$13,608.13$12,198$426.53+$30.0KTESL
4$65,225$20,088.59$13,056$467.62+$52.2KTESL
5$98,820$29,029.31$13,987$513.12+$84.8KTESL
6$146,841$41,104.01$14,998$563.56+$131.8KTESL
7$214,203$57,082.65$16,098$619.52+$198.1KTESL
8$307,018$77,821.09$17,295$681.69+$289.7KTESL
9$432,754$104,244.29$18,599$750.82+$414.2KTESL
10$600,370$137,323.62$20,022$827.78+$580.3KTESL

TESL vs JNJ: Complete Analysis 2026

TESLStock

The Simplify Volt TSLA Revolution ETF (TESL) aims to provide capital appreciation by focusing on Tesla, Inc. (NASDAQ: TSLA). This fund concentrates on Tesla-related instruments, including common stock, ETFs, swaps, and options, to capture the growth potential of Tesla as a leader in real world AI with self driving vehicles and humanoid robotics technology.

Full TESL Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TESL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TESL vs SCHDTESL vs JEPITESL vs OTESL vs KOTESL vs MAINTESL vs ABBVTESL vs MRKTESL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.